Temozolomide Capsule
Product Images NDC 82249-404

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 82249-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civicascript Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Temo-100mg-5s (Temo 100mg 5s)

This is a description for Temozolomide capsules, USP containing 100 mg per capsule designed for oral administration. The package includes 5 capsules. For more information, please refer to the packaging details provided.*

FDA Label Image

Temo-140mg-5s (Temo 140mg 5s)

This is a description of a medication called Temozolomide, which is in the form of capsules. The package contains 5 capsules of 250 mg each. It is intended for oral administration. For more information about this medication, further details can be found on the packaging.*

FDA Label Image

Temo-180mg-5s (Temo 180mg 5s)

This is a description of Temozolomide capsules, USP for oral administration. The package contains 5 capsules. For more information, refer to the medication guide.*

FDA Label Image

Temo-20mg-5s (Temo 20mg 5s)

This is a label for Temozolomide capsules, USP, with a strength of 20 mg per capsule. There are 5 capsules in the package for oral administration. For additional information, refer to the prescription.*

FDA Label Image

Temo-250mg-5s (Temo 250mg 5s)

FDA Label Image

Temo-5mg-5s (Temo 5mg 5s)

This text contains information about Temozolomide Capsules, USP, with a concentration of 5 mg per capsule. The package includes 5 capsules for oral administration. For more details, refer to the product label.*

FDA Label Image

Kaplan-meier Curves (Temo Fig2)

This text seems to provide information regarding the overall survival in a study population. It shows the hazard ratio (HR) with a 95% confidence interval of 0.63 (0.52 to 0.75) and a log-rank P-value of less than 0.0001. Additionally, it includes a timeline indicating the time from randomization in months (12, 16, 20, 24, 28). An analysis of these values can be performed to evaluate the impact on survival outcomes in the given population.*

FDA Label Image

Chemical-structure (Temo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.